140 related articles for article (PubMed ID: 6106282)
1. Angiotensin II blockade during combined thiazide-beta-blocker treatment.
Ibsen H; Leth A; McNair A; Christensen NJ; Giese J
Scand J Clin Lab Invest; 1980 Jun; 40(4):325-31. PubMed ID: 6106282
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II blockade during combined thiazide-beta-adrenoreceptor-blocker treatment.
Ibsen H; Leth A; McNair A; Giese J
Clin Sci (Lond); 1979 Dec; 57 Suppl 5():123s-125s. PubMed ID: 396064
[TBL] [Abstract][Full Text] [Related]
3. Renin release, saralasin and the vasodilator-beta-blocker drug interaction in man.
Pettinger WA; Mitchell HC
N Engl J Med; 1975 Jun; 292(23):1214-7. PubMed ID: 236513
[TBL] [Abstract][Full Text] [Related]
4. The influence of sar1 ala8 angiotensin II (saralasin) on plasma aldosterone in hypertensive patients.
Donker AJ; van Hoogdalem P; Pratt JJ; Leenen FH
Acta Med Scand; 1979; 205(3):207-12. PubMed ID: 425848
[TBL] [Abstract][Full Text] [Related]
5. Effect of blockade of angiotensin II on blood pressure, renin and aldosterone in cirrhosis.
Schroeder ET; Anderson GH; Goldman SH; Streeten DH
Kidney Int; 1976 Jun; 9(6):511-9. PubMed ID: 940284
[TBL] [Abstract][Full Text] [Related]
6. The effects of saralasin, an angiotensin II antagonist, on blood pressure and the renin-angiotensin-aldosterone system in normal and hypertensive subjects.
Brown JJ; Brown WC; Fraser R; Lever AF; Morton JJ; Robertson JI; Rosei EA; Trust PM
Aust N Z J Med; 1976 Aug; 6(3 Suppl):48-52. PubMed ID: 1071403
[TBL] [Abstract][Full Text] [Related]
7. Effects of angiotensin II blockade in the canine puppy under different salt-intake.
Fiselier TJ; Monnens LA; Lameire NH; van Munster PJ; Peer PG; Leusen IR; Lijnen PJ
Kidney Int; 1984 Dec; 26(6):823-9. PubMed ID: 6398382
[TBL] [Abstract][Full Text] [Related]
8. Blockade of renin or angiotensin for understanding human hypertension: a comparison of propranolol, saralasin and converting enzyme blockade.
Laragh JH; Case DB; Wallace JM; Keim H
Fed Proc; 1977 Apr; 36(5):1781-7. PubMed ID: 191300
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II blockade before and after marked sodium depletion in patients with hypertension.
Van Hoogdalem P; Donker AJ; Leenen FH
Clin Sci Mol Med; 1978 Jan; 54(1):75-83. PubMed ID: 620496
[TBL] [Abstract][Full Text] [Related]
10. Renin-angiotensin system in mild essential hypertension. The functional significance of angiotensin II in untreated and thiazide-treated hypertensive patients.
Ibsen H; Leth A; Hollnagel H; Kappelgaard AM; Nielsen MD; Christensen NJ; Giese J
Acta Med Scand; 1979; 205(7):547-55. PubMed ID: 474180
[No Abstract] [Full Text] [Related]
11. The renin-angiotensin system and the antihypertensive effect of atenolol in man.
Mimran A; Deschodt G; Fourcade J; Barjon P
Arch Int Pharmacodyn Ther; 1979 Sep; 241(1):100-7. PubMed ID: 526065
[TBL] [Abstract][Full Text] [Related]
12. Renin angiotensin system and sympathetic nerve activity in mild essential hypertension. The functional significance of angiotensin II in untreated and thiazide treated hypertensive patients.
Ibsen H; Leth A; Hollnagel H; Kappelgaard AM; Damkjaer M; Nielsen MD; Christensen NJ; Giese J
Acta Med Scand Suppl; 1979; 625():97-102. PubMed ID: 285581
[No Abstract] [Full Text] [Related]
13. The effect of an angiotensin antagonist (saralasin) on arterial pressure and plasma aldosterone in hemodialysis-resistant hypertensive patients.
Mimran A; Shaldon S; Barjon P; Mion C
Clin Nephrol; 1978 Feb; 9(2):63-7. PubMed ID: 639368
[TBL] [Abstract][Full Text] [Related]
14. Effects of the angiotensin II antagonist 1-sar-8-ala-angiotensin II in hypertension in man.
Fagard R; Amery A; Lijnen P; Reybrouck T
Eur J Clin Invest; 1977 Dec; 7(6):473-9. PubMed ID: 415868
[TBL] [Abstract][Full Text] [Related]
15. Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin.
Case DB; Wallace JM; Keim HJ; Weber MA; Drayer JI; White RP; Sealey JE; Laragh JH
Am J Med; 1976 Nov; 61(5):790-6. PubMed ID: 185903
[TBL] [Abstract][Full Text] [Related]
16. Effects of 1-sar-8-ala-angiotensin II on arterial pressure, renin and aldosterone in hypertension.
Fagard R; Lijnen P; Amery A; Reybrouck T
Contrib Nephrol; 1978; 11():175-8. PubMed ID: 699588
[TBL] [Abstract][Full Text] [Related]
17. Effect of angiotensin-II blockade on systemic and hepatic haemodynamics and on the renin-angiotensin-aldosterone system in cirrhosis with ascites.
Arroyo V; Bosch J; Mauri M; Ribera F; Navarro-López F; Rodés J
Eur J Clin Invest; 1981 Jun; 11(3):221-9. PubMed ID: 6791942
[TBL] [Abstract][Full Text] [Related]
18. Effect of the angiotensin II antagonist saralasin on plasma aldosterone concentration and on blood pressure before and during sodium depletion in normal subjects.
Agabiti-Rosei E; Brown JJ; Brown WC; Fraser R; Trust PM; Lever AF; Morton JJ; Robertson JI
Clin Endocrinol (Oxf); 1979 Mar; 10(3):227-34. PubMed ID: 455738
[TBL] [Abstract][Full Text] [Related]
19. The effect of angiotensin II blockade by saralasin (1-Sar-8-Ala-angiotensin II) in normal man.
Ibsen H; Kappelgaard AM; Nielsen MD; Giese J
Eur J Clin Pharmacol; 1978 Nov; 14(3):171-6. PubMed ID: 729612
[No Abstract] [Full Text] [Related]
20. Changes in plasma norepinephrine after intravertebral artery infusion of saralasin in sodium depleted dogs.
Arita M; Ueno Y; Suruda H; Mohara O; Nishio I; Masuyama Y
Jpn Circ J; 1983 Mar; 47(3):336-41. PubMed ID: 6339771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
